Literature DB >> 20206653

Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.

Sooyeon Jung1, Soo Hyeon Lee, Hyejung Mok, Hyun Jung Chung, Tae Gwan Park.   

Abstract

Small interfering RNA (siRNA) was conjugated with poly(ethylene glycol) (PEG) at four different terminal ends (sense 3', sense 5', antisense 3', and antisense 5') via cleavable disulfide and noncleavable thioether linkages to evaluate their gene silencing efficiencies upon complexation with Lipofectamine2000. The PEGylation site at the four siRNA termini and PEG molecular weight were not critical factors to significantly affect gene silencing activities. Cleavable siRNA-PEG conjugates showed comparable gene silencing activities to naked siRNA, and exhibited sequence-specific degradation of a target mRNA. Interestingly, noncleavable siRNA-PEG conjugates were processed by Dicer, enabling to exert RNAi effect without showing a target sequence-specific manner. However, only cleavable siRNA-PEG conjugates significantly reduced the extent of INF-alpha release as compared to noncleavable siRNA-PEG conjugates, suggesting that they can be potentially used for therapeutic siRNA applications. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206653     DOI: 10.1016/j.jconrel.2010.03.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  21 in total

Review 1.  Self-assembled and nanostructured siRNA delivery systems.

Authors:  Ji Hoon Jeong; Tae Gwan Park; Sun Hwa Kim
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

2.  PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures.

Authors:  Xueguang Lu; Ke Zhang
Journal:  Nano Res       Date:  2018-07-06       Impact factor: 8.897

Review 3.  The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

Authors:  Ulrich H Weidle; Steffen Dickopf; Corinna Hintermair; Gwendlyn Kollmorgen; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 4.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

Review 5.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

6.  Stabilization and photochemical regulation of antisense agents through PEGylation.

Authors:  Jeane M Govan; Andrew L McIver; Alexander Deiters
Journal:  Bioconjug Chem       Date:  2011-09-30       Impact factor: 4.774

Review 7.  Nanomaterials for cancer therapy and imaging.

Authors:  Ki Hyun Bae; Hyun Jung Chung; Tae Gwan Park
Journal:  Mol Cells       Date:  2011-02-25       Impact factor: 5.034

Review 8.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Authors:  Jing Xu; Shanthi Ganesh; Mansoor Amiji
Journal:  Int J Pharm       Date:  2011-05-19       Impact factor: 5.875

9.  CpG-PEG Conjugates and their Immune Modulating Effects after Systemic Administration.

Authors:  Caixing Wu; Xiaofei Xiang; Yang Yue; Lin Li; Yesen Li; Chong Zhang; Yuhong Xu
Journal:  Pharm Res       Date:  2018-03-02       Impact factor: 4.200

10.  Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.

Authors:  Li Gu; Leora M Nusblat; Nasim Tishbi; Sarah C Noble; Chaya M Pinson; Evan Mintzer; Charles M Roth; Kathryn E Uhrich
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.